Viacell, Inc. 8-K dated May 10, 2005
Table of Contents

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 10, 2005

VIACELL, INC.


(Exact name of registrant as specified in its charter)

         
Delaware   000-51110   04-3244816
         
(State or other jurisdiction
of incorporation or organization)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

245 First Street, Cambridge, Massachusetts 02142


(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (617) 914-3400

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02. Results of Operations and Financial Condition
Item 9.01 Financial Statements and Exhibits.
SIGNATURE
INDEX TO EXHIBITS
EX-99.1 Press Release dated May 10, 2005


Table of Contents

Item 2.02. Results of Operations and Financial Condition

     On May 10, 2005, ViaCell, Inc. issued a press release relating to its results of operations and financial condition for the quarter ended March 31, 2005. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits

     99.1            Press Release of ViaCell, Inc. dated May 10, 2005.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
  VIACELL, INC.
 
 
  By:   /s/ STEPHEN DANCE    
 
    Name:   Stephen Dance   
Date: May 10, 2005    Title:   Chief Financial Officer   
 

 


Table of Contents

INDEX TO EXHIBITS

         
Exhibit No.   Description
       
 
  99.1    
Press Release of ViaCell, Inc. dated May 10, 2005.